Elevated serum levels of CXCL10, along with CXCL9 and CXCL11, are linked to poorer prognosis in MM patients [93], indicating a possible role for CXCR3 ligands in the tumor-promoting processes of MM. Here, CXCL9 is linked to Miyoshi myopathy.